Antimicrobial Susceptibility Testing Market by Product (Automated System, Disks, MIC Strips, Media), Method (Dilution, Diffusion), Type (Antibacterial, Antifungal), Application (Clinical, Drug Discovery), End User (Labs, Hospitals) - Global Forecast to 2022

The global antimicrobial susceptibility testing market is expected to reach USD 3.47 Billion by 2022 from USD 2.58 Billion in 2016, at a CAGR of 5.1%.

The time frame considered for the study is as follows:

• Base Year: 2016
• Forecast Period: 2017–2022

Objectives of the study are:

• To define, describe, segment, and forecast the global market by method, product, type, application, end user, and region
• To provide detailed information regarding the major factors influencing the growth of the global market (drivers, restraints, opportunities, and challenges)
• To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the total market
• To analyze the growth opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To provide a five-year forecast (2017–2022) for various segments of the global market, in terms of revenue, with respect to four main geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World
• To profile the key players and comprehensively analyze their market shares and core competencies
• To track and analyze competitive developments such as product launches; agreements, partnerships, and collaborations; geographic expansions; joint ventures; and mergers and acquisitions in the global market

This research study involves the extensive use of secondary sources, directories, and databases, to identify and collect information useful for this technical, market-oriented, and financial study of the antimicrobial susceptibility testing market. In-depth interviews were conducted with various primary respondents, including subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify qualitative and quantitative information and to assess market prospects.

To know about the assumptions considered for the study, download the pdf brochure

As of 2016, bioMérieux (France), Danaher (US), BD (US), Thermo Fisher (US), and Bio-Rad (US) held the leading position in the global AST market. These companies adopted product launches, enhancements, agreements, partnerships, and collaborations as their key growth strategies in the past three years. Hi-Media (India), MERLIN (Germany), Liofilchem (Italy), Accelerate (US), Alifax (Italy), Creative Diagnostics (US), Merck (Germany), Synbiosis (UK), Bioanalyse (Turkey), and Zhuhai DL Biotech (China) are some of the other major players operating in this market.

Stakeholders

• Antimicrobial susceptibility testing product manufacturers and vendors
• Associations related to antimicrobial susceptibility testing
• Clinical research organizations (CROs)
• Research laboratories and academic institutes
• Pharmaceutical and biotechnology product manufacturing companies
• Clinical testing laboratories
• Hospitals and diagnostic laboratories
• Environmental monitoring committee
• Market research and consulting firms

Scope of the Report

This report categorizes the global AST market into the following segments and subsegments:

Global AST Market, By Product

• Automated Laboratory Instruments
• Manual Antimicrobial Susceptibility Testing Products
• Susceptibility Testing Disks
• MIC strips
• Susceptibility Plates
• Culture and Growth Media
• Consumables

Global AST Market, By Method

• Dilution
• Disk Diffusion
• ETEST
• Automated Antimicrobial Susceptibility Testing
• Genotypic Methods

Global AST Market, By Type

• Antibacterial Testing
• Antifungal Testing
• Antiparasitic Testing
• Others Susceptibility Testing

Note: Others include viruses and fastidious organism testing among others

Antimicrobial Susceptibility Testing Market, By Application

• Clinical Diagnostics
• Drug Discovery and Development
• Epidemiology
• Other Applications

Note: Other applications include veterinary diagnostics, Bioterrorism Surveillance, environmental monitoring, research and academic applications,

Antimicrobial Susceptibility Testing Market, By End User

• Diagnostic Centers and Hospitals
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Research and Academic Institutes

Global AST Market, By Region

• North America
  • US
  • Canada
• Europe
• Asia Pacific
• Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

Product matrix which gives a detailed comparison of the product portfolios of the top five companies

Company Information

Detailed analysis and profiling of additional market players (up to 5)

Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 19)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Data Triangulation Methodology
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 28)

4 Premium Insights (Page No. - 33)
    4.1 Attractive Opportunities in Antimicrobial Susceptibility Testing Market
    4.2 Global Market, By Method
    4.3 Geographic Analysis: Global Market, By Region & Product
    4.4 Global Market, By Type
    4.5 Global Market, By Application
    4.6 Global Market, By End User
    4.7 Geographical Snapshot of the Global Market

5 Market Overview (Page No. - 39)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Prevalence of Infectious Diseases
                    5.2.1.2 Increased Funding, Research Grants, and Public-Private Investments
                    5.2.1.3 Technological Advancements Towards the Development of Rapid Ast Methods
                    5.2.1.4 Emergence of Multidrug Resistance Due to Drug Abuse
           5.2.2 Restraints
                    5.2.2.1 Unfavorable Reimbursement Scenario
           5.2.3 Opportunities
                    5.2.3.1 Emerging Markets to Offer Lucrative Opportunities
                    5.2.3.2 Initiatives to Detect and Control Antimicrobial-Resistant Species
           5.2.4 Challenges
                    5.2.4.1 High Cost of Automated Antimicrobial Susceptibility Testing Systems
                    5.2.4.2 Lack of Coordination Between Regulatory Bodies, Clinical Laboratories, and Ast Manufacturers
    5.3 Market Trends

6 By Method (Page No. - 48)
    6.1 Introduction
    6.2 Disk Diffusion
    6.3 Automated Ast
    6.4 Dilution
    6.5 Etest
    6.6 Genotypic Methods

7 By Product (Page No. - 55)
    7.1 Introduction
    7.2 Manual Antimicrobial Susceptibility Testing Products
           7.2.1 Susceptibility Testing Disks
           7.2.2 Mic Strips
           7.2.3 Susceptibility Plates
    7.3 Automated Laboratory Instruments
    7.4 Culture and Growth Media
    7.5 Consumables

8 By Type (Page No. - 66)
    8.1 Introduction
    8.2 Antibacterial Susceptibility Testing
    8.3 Antifungal Susceptibility Testing
    8.4 Antiparasitic Susceptibility Testing
    8.5 Other Susceptibility Testing

9 By Application (Page No. - 73)
    9.1 Introduction
    9.2 Clinical Diagnostics
    9.3 Drug Discovery and Development
    9.4 Epidemiology
    9.5 Other Applications

10 By End User (Page No. - 80)
     10.1 Introduction
     10.2 Diagnostic Laboratories and Hospitals
     10.3 Pharmaceutical and Biotechnology Companies
     10.4 Research and Academic Institutes
     10.5 Contract Research Organizations

11 By Region (Page No. - 87)
     11.1 Introduction
     11.2 North America
             11.2.1 Us
             11.2.2 Canada
     11.3 Europe
     11.4 Asia Pacific
     11.5 Rest of the World

12 Competitive Landscape (Page No. - 113)
     12.1 Introduction
     12.2 Ranking of Players, 2016
     12.3 Competitive Scenario
             12.3.1 Product Launches and Enhancements
             12.3.2 Acquisitions
             12.3.3 Agreements and Collaborations
             12.3.4 Expansions

13 Company Profiles (Page No. - 117)
(Business Overview, Products Offered, SWOT Anlysis, MnM View.)*
     13.1 Biomérieux
     13.2 Danaher
     13.3 BD
     13.4 Thermo Fisher
     13.5 Bio-Rad
     13.6 Hi-Media
     13.7 Merlin
     13.8 Liofilchem
     13.9 Accelerate Diagnostics
     13.10 Alifax
     13.11 Creative Diagnostics
     13.12 Merck Group
     13.13 Synbiosis
     13.14 Bioanalyse
     13.15 Zhuhai Dl Biotech

*Business Overview, Products Offered, SWOT Anlysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 153)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.4 Introducing RT: Real-Time Market Intelligence
     14.5 Available Customizations
     14.6 Related Reports
     14.7 Author Details

List of Tables (62 Tables)

Table 1 Global Antimicrobial Susceptibility Testing Market, By Method, 2015–2022 (USD Million)
Table 2 Global Disk Diffusion Market, By Region, 2015–2022 (USD Million)
Table 3 Global Automated Ast Market, By Region, 2015–2022 (USD Million)
Table 4 Global Dilution Market, By Region, 2015–2022 (USD Million)
Table 5 Global Etest Market, By Region, 2015–2022 (USD Million)
Table 6 Global Genotypic Methods Market, By Region, 2015–2022 (USD Million)
Table 7 Antimicrobial Susceptibility Testing Market, By Product, 2015–2022 (USD Million)
Table 8 Manual Antimicrobial Susceptibility Testing Products Market, By Type, 2015–2022 (USD Million)
Table 9 Manual Antimicrobial Susceptibility Testing Products Market, By Region, 2015–2022 (USD Million)
Table 10 Susceptibility Testing Disks Market, By Region, 2015–2022 (USD Million)
Table 11 Mic Strips Market, By Region, 2015–2022 (USD Million)
Table 12 Susceptibility Plates Market, By Region, 2015–2022 (USD Million)
Table 13 Automated Laboratory Instruments Market, By Region, 2015–2022 (USD Million)
Table 14 Culture and Growth Market, By Region, 2015–2022 (USD Million)
Table 15 Consumables Market, By Region, 2015–2022 (USD Million)
Table 16 Antimicrobial Susceptibility Testing Market, By Type, 2015–2022 (USD Million)
Table 17 Antibacterial Susceptibility Testing Market, By Region, 2015–2022 (USD Million)
Table 18 Antifungal Susceptibility Testing Market, By Region, 2015–2022 (USD Million)
Table 19 Antiparasitic Susceptibility Testing Market, By Region, 2015–2022 (USD Million)
Table 20 Other Susceptibility Testing Market, By Region, 2015–2022 (USD Million)
Table 21 Global Market, By Application, 2015–2022 (USD Million)
Table 22 Global Market for Clinical Diagnostics, By Region, 2015–2022 (USD Million)
Table 23 Global Market for Drug Discovery and Development, By Region, 2015–2022 (USD Million)
Table 24 Global Epidemiology Market, By Region, 2015–2022 (USD Million)
Table 25 Global Market for Other Applications, By Region, 2015–2022 (USD Million)
Table 26 Global Market, By End User, 2015–2022 (USD Million)
Table 27 Global Market for Diagnostic Laboratories and Hospitals, By Region, 2015–2022 (USD Million)
Table 28 Antimicrobial Susceptibility Testing Market for Pharmaceutical and Biotechnology Companies, By Region, 2015–2022 (USD Million)
Table 29 Global Market for Research and Academic Institutes, By Region, 2015–2022 (USD Million)
Table 30 Global Market for Cros Market, By Region, 2015–2022 (USD Million)
Table 31 Global Market, By Region, 2015–2022 (USD Million)
Table 32 North America: Antimicrobial Susceptibility Testing Market, By Country, 2015–2022 (USD Million)
Table 33 North America: Market, By Product, 2015–2022 (USD Million)
Table 34 North America: Market, By Method, 2015–2022 (USD Million)
Table 35 North America: Market, By Type, 2015–2022 (USD Million)
Table 36 North America: Market, By Application, 2015–2022 (USD Million)
Table 37 North America: Market, By End User, 2015–2022 (USD Million)
Table 38 US: Antimicrobial Susceptibility Testing Market, By Product, 2015–2022 (USD Million)
Table 39 US: Market, By Method, 2015–2022 (USD Million)
Table 40 US: Market, By Type, 2015–2022 (USD Million)
Table 41 US: Market, By Application, 2015–2022 (USD Million)
Table 42 US: Market, By End User, 2015–2022 (USD Million)
Table 43 Canada: Antimicrobial Susceptibility Testing Market, By Product, 2015–2022 (USD Million)
Table 44 Canada: Market, By Method, 2015–2022 (USD Million)
Table 45 Canada: Market, By Type, 2015–2022 (USD Million)
Table 46 Canada: Market, By Application, 2015–2022 (USD Million)
Table 47 Canada: Market, By End User, 2015–2022 (USD Million)
Table 48 Europe: Antimicrobial Susceptibility Testing Market, By Product, 2015–2022 (USD Million)
Table 49 Europe: Market, By Method, 2015–2022 (USD Million)
Table 50 Europe: Market, By Type, 2015–2022 (USD Million)
Table 51 Europe: Market, By Application, 2015–2022 (USD Million)
Table 52 Europe: Market, By End User, 2015–2022 (USD Million)
Table 53 Asia Pacific: Antimicrobial Susceptibility Testing Market, By Product, 2015–2022 (USD Million)
Table 54 Asia Pacific: Market, By Method, 2015–2022 (USD Million)
Table 55 Asia Pacific: Market, By Type, 2015–2022 (USD Million)
Table 56 Asia Pacific: Market, By Application, 2015–2022 (USD Million)
Table 57 Asia Pacific: Market, By End User, 2015–2022 (USD Million)
Table 58 RoW: Antimicrobial Susceptibility Testing Market, By Product, 2015–2022 (USD Million)
Table 59 RoW: Market, By Method, 2015–2022 (USD Million)
Table 60 RoW: Market, By Type, 2015–2022 (USD Million)
Table 61 RoW: Market, By Application, 2015–2022 (USD Million)
Table 62 RoW: Market, By End User, 2015–2022 (USD Million)

List of Figures (38 Figures)

Figure 1 Global Antimicrobial Susceptibility Testing Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Supply-Side Primary Interviews: By Company Type, Designation, and Region
Figure 4 Data Triangulation
Figure 5 Global Market, By Method, 2017
Figure 6 Manual Antimicrobial Susceptibility Testing Products Will Continue to Hold Largest Share in 2022
Figure 7 Global Market, By Type, 2017 (USD Million)
Figure 8 Antimicrobial Susceptibility Testing Market, By Application, 2017 (USD Million)
Figure 9 Global Market, By End User, 2017 vs 2022 (USD Million)
Figure 10 Asia Pacific Market to Grow at the Highest CAGR During the Forecast Period
Figure 11 Rising Prevalence of Infectious Diseases—Major Factor Driving Market Growth
Figure 12 Disk Diffusion Segment Will Continue to Dominate the Market in 2022
Figure 13 Manual Antimicrobial Susceptibility Testing Products to Dominate the Global Antimicrobial Susceptibility Testing Market in 2017
Figure 14 Antibacterial Susceptibility Testing Segment Will Continue to Dominate the Market in 2022
Figure 15 Clinical Diagnostics Segment to Account for the Largest Market Share in 2022
Figure 16 Hospitals & Diagnostic Laboratories to Register the Highest Growth Rate in the Forecast Period
Figure 17 Asia Pacific to Witness the Highest CAGR During the Forecast Period
Figure 18 Antimicrobial Susceptibility Testing Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Deaths Attributable to Antimicrobial Resistance Per Year By 2050
Figure 20 Disk Diffusion Segment to Dominate the Global Antimicrobial Susceptibility Testing Method Market During the Forecast Period
Figure 21 Manual Antimicrobial Susceptibility Testing Products to Dominate the Market During the Forecast Period
Figure 22 Susceptibility Testing Disks to Dominate the Manual Ast Products Market During the Forecast Period
Figure 23 Antibacterial Testing Segment to Dominate the Antimicrobial Susceptibility Testing Market in 2017
Figure 24 Clinical Diagnostics Segment to Dominate the Global Market in 2017
Figure 25 Diagnostic Laboratories and Hospitals Segment to Dominate the Global Market in 2017
Figure 26 North America: Market Snapshot
Figure 27 Europe: Market Snapshot
Figure 28 Asia Pacific: Market Snapshot
Figure 29 RoW: Market Snapshot
Figure 30 Key Developments By Leading Market Players in the Antimicrobial Susceptibility Testing Market, 2014–2017
Figure 31 Biomérieux Held the Leading Position in the Global Market in 2016
Figure 32 Biomérieux: Company Snapshot
Figure 33 Danaher: Company Snapshot
Figure 34 BD: Company Snapshot
Figure 35 Thermo Fisher: Company Snapshot
Figure 36 Bio-Rad: Company Snapshot
Figure 37 Accelerate Diagnostics: Company Snapshot
Figure 38 Merck Group: Company Snapshot

The global antimicrobial susceptibility testing market is expected to reach USD 3.47 Billion by 2022 from USD 2.71 Billion in 2017, at a CAGR of 5.1%. Factors such as increasing prevalence of infectious diseases across the globe, emergence of antimicrobial resistance caused due to drug overuse, increasing initiatives by government organizations towards improving the detection and control antimicrobial resistant species, and improving growth opportunities in emerging markets are boosting the demand for antimicrobial susceptibility testing products.

This report broadly segments the antimicrobial susceptibility testing (AST) market into product, method, type, application, end user, and region.

By method, the market is segmented into disk diffusion, dilution, ETEST, automated susceptibility testing, and genotypic methods. Growth in this segment can largely be attributed to its low cost and the flexible nature of these methods.

By product, the global market is segmented into automated laboratory instruments, manual antimicrobial susceptibility testing products, culture and growth media, and consumables. The manual susceptibility testing products segment is expected to command the largest share of the global AST market in 2017. This is attributed to factors such as the rising prevalence of infectious diseases leading to an increased demand for susceptibility testing products and benefits such as low cost and the ease of use of these products.

The global antimicrobial susceptibility testing market is segmented by type into antibacterial, antifungal, antiparasitic, and other susceptibility testing types (mycobacterium and virus). The antibacterial testing segment dominated the market in 2017. The largest share of this market can be attributed to factors such as increasing prevalence of infections due to bacterial pathogens and increasing guidelines streamlining the process of AST.

By application, the global market is segmented into clinical diagnostics, drug discovery and development, epidemiology, and other applications. The other applications segment includes veterinary diagnostics, bioterrorism surveillance, and environmental monitoring. The clinical diagnostics segment accounted for the largest share in 2017. A number of factors such as the increasing prevalence of infectious diseases, the rising burden of antimicrobial resistance, and growing awareness about the use of antimicrobial susceptibility testing methods for diagnostic applications are responsible for the large market share of this application segment.

On the basis of end users, the global AST market is segmented into diagnostic laboratories and hospitals; pharmaceutical and biotechnology companies; contract research organizations; and research and academic institutes. The hospitals and diagnostic laboratories segment is estimated to command the largest share of the antimicrobial susceptibility testing market in 2017. Some of the factors driving the growth of this segment are the increasing prevalence of infectious diseases, increasing healthcare expenditure, and the increasing number of initiatives towards better antibiotic use.

The report covers the antimicrobial susceptibility testing market across four key geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the global AST market primarily due to easy accessibility and better adoption of technologically advanced susceptibility testing methods and products. The increasing prevalence of antimicrobial resistance in North America is another key factor supporting the growth of this regional segment in the global market. The Asia Pacific is expected to grow at the fastest CAGR as markets in developed countries are increasingly becoming saturated and manufacturers and suppliers of AST products are shifting their focus towards the Asian market.

Factors such as an unfavorable reimbursement scenario may hinder the growth of the market to a certain extent.

As of 2016, some of the major players operating in this market include bioMérieux (France), BD (US), Danaher (US), Thermo Fisher (US), and Bio-Rad (US).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst